CAN:s bibliotek

*000      am
*00116043
*008070120|1996|||||||||||e||||||||||0|eng|d
*020  $a3-540-58989-9$x3-540-58989-9
*24510$aPharmacological aspects of drug dependence :$btoward an integrated neurobehavioral approach
*260  $aBerlin :$bSpringer,$ccop. 1996$y1996
*300  $a658 s :$bill.
*440 0$aHandbook of experimental pharmacology ;$v118
*520  $aGenetic vulnerability to substance abuse. Integrative neurobehavioral pharmacology: focus on cocaine. Molecular, behavioral, and human pharmacology of dependence and consequences. Cocaine. Opioid analgesics. Phencyclidine: a drug of abuse and a tool for neuroscience research. Benzodiazepine discontinuation syndromes: clinical and experimental aspects. Nicotine. Caffeine reinforcement, discrimination, tolerance and physical dependence in laboratory animals and humans. Classical hallucinogens. Alcohol. Pharmacotherapy of addiction: introduction and principles. Development of medications for addictive disorders. Long-term pharmacotherapy for opiate (primarily heroin) addiction: opioid agonists. Long-term pharmacotherapy for opiate (primarily heroin) addiction: opioid antagonists and partial agonists. Pharmacotherapy of nicotine dependence. Pharmacotherapies for cocaine dependence.
*650 4$aDrug therapy
*650 4$aBehavior, Addictive
*650 4$aPharmacokinetics
*650 4$aPharmacology
*650 4$aBrain
*650 4$aGenetics
*650 4$aCocaine
*650 4$aMarijuana smoking
*650 4$aAnalgesics, opioid
*650 4$aNarcotics
*650 4$aPhencyclidine
*650 4$aPhencyclidine abuse
*650 4$aBenzodiazepines
*650 4$aNicotine
*650 4$aCaffeine
*650 4$aEthanol
*650 4$aHallucinogens
*650 4$aHeroin dependence
*650 4$aCocaine-related disorders
*650 4$aNarcotic antagonists
*653  $aFarmakoterapi
*653  $aNarkotika
*653  $aAlkohol
*653  $aBensodiazepiner
*653  $aNikotin
*7001 $aBalster, R.L.$eet al
*7001 $aSchuster, Charles R.$eed.
*7001 $aKuhar, Michael J.$eed.
*852  $h4a104 Ref
^